KENLIFABI Trademark Information

Trademark by Idorsia Pharmaceuticals Ltd

Pharmaceutical products for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, and for the treatment of glycolipid storage disorders

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: KENLIFABI
Status/Status Date:
NEW APPLICATION FILED
7/17/2021
Serial Number: 90827353
Filing Date: 7/14/2021
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical products for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, and for the treatment of glycolipid storage disorders
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner:
Idorsia Pharmaceuticals Ltd
Allschwil 4123
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
PRANGER LAW PC
88 GUY PLACE, SUITE 405
SAN FRANCISCO, CA 94105
Current Status:
NEW APPLICATION FILED
7/17/2021
Correspondent Search:
GAIL I. NEVIUS ABBAS is a correspondent of KENLIFABI trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on